mianserin has been researched along with Bradyarrhythmia in 4 studies
Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.
| Excerpt | Relevance | Reference |
|---|---|---|
| "An acute episode of symptomatic sinus bradycardia, occurred in a 50-year-old female patient after she had been given a single therapeutic dose of mianserin." | 7.68 | Symptomatic bradycardia caused by mianserin at therapeutic doses. ( Carcone, B; Chaillet, N; Descotes, J; Vial, T, 1991) |
| "An acute episode of symptomatic sinus bradycardia, occurred in a 50-year-old female patient after she had been given a single therapeutic dose of mianserin." | 3.68 | Symptomatic bradycardia caused by mianserin at therapeutic doses. ( Carcone, B; Chaillet, N; Descotes, J; Vial, T, 1991) |
| "Mirtazapine is a commonly prescribed antidepressant drug, which is also metabolized through and may modulate the CYP4502D6 pathway leading to altered metabolism of propafenone and possible adverse effects." | 1.40 | Propafenone associated severe central nervous system and cardiovascular toxicity due to mirtazapine: a case of severe drug interaction. ( Aryal, SR; Khan, MA; Rajpurohit, N; Stys, AT; Stys, TP, 2014) |
| "Serotonin syndrome is caused by excess serotonin in the central nervous system." | 1.37 | [Serotonin syndrome in the course of drug-poisoning--case presentation]. ( Kostek, H; Kujawa, A; Majewska, M; Pyra, E; Szponar, J, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rajpurohit, N | 1 |
| Aryal, SR | 1 |
| Khan, MA | 1 |
| Stys, AT | 1 |
| Stys, TP | 1 |
| Koseoglu, Z | 1 |
| Kara, B | 1 |
| Satar, S | 1 |
| Majewska, M | 1 |
| Szponar, J | 1 |
| Pyra, E | 1 |
| Kostek, H | 1 |
| Kujawa, A | 1 |
| Carcone, B | 1 |
| Vial, T | 1 |
| Chaillet, N | 1 |
| Descotes, J | 1 |
4 other studies available for mianserin and Bradyarrhythmia
| Article | Year |
|---|---|
Propafenone associated severe central nervous system and cardiovascular toxicity due to mirtazapine: a case of severe drug interaction.
Topics: Aged; Anti-Arrhythmia Agents; Antidepressive Agents, Tricyclic; Atrial Fibrillation; Bradycardia; Di | 2014 |
Bradycardia and hypotension in mianserin intoxication.
Topics: Adult; Anti-Arrhythmia Agents; Antidepressive Agents, Second-Generation; Atropine; Bradycardia; Fema | 2010 |
[Serotonin syndrome in the course of drug-poisoning--case presentation].
Topics: Alcoholic Intoxication; Alkaloids; Azocines; Bradycardia; Cyclohexanols; Depressive Disorder; Electr | 2011 |
Symptomatic bradycardia caused by mianserin at therapeutic doses.
Topics: Bradycardia; Electrocardiography; Female; Humans; Mianserin; Middle Aged | 1991 |